Innovative platinum derived anticancer agents – risk or opportunity?

Steve C.F. Au-Yeung, Patrick S.K. Pang, Yee-ping Ho
  • Nature Reviews Drug Discovery, September 2006, Nature Publishing Group
  • DOI: 10.1038/nrd1691-c1

Toxicity - anticancer activity relationship, Platinum anticancer drugs

The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Siu-Kwong Pang